STOCK TITAN

Zomedica to Report Third Quarter 2023 Financial Results and Provide Business Update on November 13 at 4:30 p.m. ET

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Zomedica Corp. will host a conference call and webcast on November 13, 2023, to discuss its operational and financial highlights for Q3 2023. The call will be followed by a question-and-answer session. Interested individuals can access the webcast and a dial-in replay of the call.
Positive
  • None.
Negative
  • None.

ANN ARBOR, MI / ACCESSWIRE / November 2, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for companion animals, will host a conference call and audio-only webcast on Monday, November 13, 2023 at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its third quarter ended September 30, 2023. A question-and-answer session will follow management's prepared remarks.

Event: Zomedica Q3 2023 Financial Results Conference Call
Date: Monday, November 13, 2023
Time: 4:30 p.m. Eastern Time
Live Call: +1-877-407-0789 (U.S. Toll-Free) or +1-201-689-8562 (International)
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1641216&tp_key=4fcf4cae49

For interested individuals unable to join the conference call, a dial-in replay of the call will be available until Monday, November 27, 2023 at 11:59 PM ET and can be accessed by dialing +1-844-512-2921 (U.S. Toll-Free) or +1-412-317-6671 (International) and entering replay pin number: 13742390.

About Zomedica

Based in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for companion animals by focusing on the unmet needs of clinical veterinarians. Zomedica's product portfolio will include innovative diagnostics and medical devices that emphasize patient health and practice health. It is Zomedica's mission to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. For more information, visit www.ZOMEDICA.com.

Follow Zomedica

Email Alerts: http://investors.zomedica.com
LinkedIn: https://www.linkedin.com/company/zomedica
Facebook: https://m.facebook.com/zomedica
Twitter: https://twitter.com/zomedica
Instagram: https://www.instagram.com/zomedica_inc

Investor Relations Contact:

Zomedica Investor Relations
investors@zomedica.com
1-734-369-2555

SOURCE: Zomedica Corp.



View source version on accesswire.com:
https://www.accesswire.com/798109/zomedica-to-report-third-quarter-2023-financial-results-and-provide-business-update-on-november-13-at-430-pm-et

FAQ

When will Zomedica host the conference call?

Zomedica will host the conference call on Monday, November 13, 2023.

What is the purpose of the conference call?

The conference call is for discussing Zomedica's operational and financial highlights for Q3 2023.

What time will the conference call take place?

The conference call will start at 4:30 p.m. Eastern Time.

How can I join the conference call?

To join the conference call, dial +1-877-407-0789 (U.S. Toll-Free) or +1-201-689-8562 (International).

Will there be a webcast of the conference call?

Yes, a webcast of the conference call will be available at https://viavid.webcasts.com/starthere.jsp?ei=1641216&tp_key=4fcf4cae49.

How long will the dial-in replay of the call be available?

The dial-in replay of the call will be available until Monday, November 27, 2023, at 11:59 PM ET.

What are the replay dial-in numbers?

The replay dial-in numbers are +1-844-512-2921 (U.S. Toll-Free) or +1-412-317-6671 (International).

What is the replay pin number?

The replay pin number is 13742390.

Zomedica Corp.

NYSE:ZOM

ZOM Rankings

ZOM Latest News

ZOM Stock Data

165.12M
963.34M
1.59%
8.89%
6.53%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
ANN ARBOR

About ZOM

zomedica (nyse american:zom) (tsx-v:zom) is a veterinary diagnostic and pharmaceutical and company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. zomedica’s product portfolio will include novel diagnostics and innovative therapeutics that emphasize patient health and practice health. with a team that includes clinical veterinary professionals, it is zomedica’s mission to give veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care.